Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon M Wang

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Managed Care Pharmacy : JMCP|October 26, 2013
Benefit restrictions and gout treatmentSharon M Wang, Gustavus A Aranda, Sara Gao, et al.
BMC Medical Informatics and Decision Making|March 19, 2013
Evaluation of a drug-drug interaction: fax alert intervention programEdward P Armstrong, Sharon M Wang, Lisa E Hines, et al.
Journal of Managed Care & Specialty Pharmacy|April 26, 2014
Prescriber perceptions of a near real-time fax alert program for potential drug-drug interactionsEdward P Armstrong, Sharon M Wang, Lisa E Hines, et al.
Menopause (New York, N.Y.)|October 26, 2018
Evolution of postmenopausal hormone therapy between 2002 and 2009Bruce Ettinger, Sharon M Wang, R Scott Leslie, et al.
Menopause (New York, N.Y.)|December 31, 2011
Evolution of postmenopausal hormone therapy between 2002 and 2009Bruce Ettinger, Sharon M Wang, R Scott Leslie, et al.
Journal of Medical Economics|May 20, 2009
Budget impact analysis of darbepoetin alfa every 3 weeks versus epoetin alfa every week for the treatment of chemotherapy-induced anaemia from a US payer's perspectiveRobert J Rubin, John A Glaspy, John L Adams, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 22, 2026
Cost-effectiveness of control-IQ automated insulin delivery in adults with type 1 diabetes in SwedenJohan Jendle, Nuno Picado, Carolina Bulhosa, et al.
The American Journal of Managed Care|January 9, 2026
HEDIS glycemic goal achieved using control-IQ TechnologyBimal V Patel, Sharon M Wang, Laurel H Messer, et al.
Diabetes, Obesity & Metabolism|May 5, 2026
Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients With Type 2 Diabetes in the United StatesNeda Al Rawashdh, Bimal V Patel, Sharon M Wang, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 4, 2025
Retrospective analysis of impact of automated insulin delivery technology on acute care utilisation from 2019 to 2021Janna Manjelievskaia, Viral N Shah, Anders L Carlson, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Managed Care Pharmacy : JMCP|October 26, 2013
Benefit restrictions and gout treatmentSharon M Wang, Gustavus A Aranda, Sara Gao, et al.
BMC Medical Informatics and Decision Making|March 19, 2013
Evaluation of a drug-drug interaction: fax alert intervention programEdward P Armstrong, Sharon M Wang, Lisa E Hines, et al.
Journal of Managed Care & Specialty Pharmacy|April 26, 2014
Prescriber perceptions of a near real-time fax alert program for potential drug-drug interactionsEdward P Armstrong, Sharon M Wang, Lisa E Hines, et al.
Menopause (New York, N.Y.)|October 26, 2018
Evolution of postmenopausal hormone therapy between 2002 and 2009Bruce Ettinger, Sharon M Wang, R Scott Leslie, et al.
Menopause (New York, N.Y.)|December 31, 2011
Evolution of postmenopausal hormone therapy between 2002 and 2009Bruce Ettinger, Sharon M Wang, R Scott Leslie, et al.
Journal of Medical Economics|May 20, 2009
Budget impact analysis of darbepoetin alfa every 3 weeks versus epoetin alfa every week for the treatment of chemotherapy-induced anaemia from a US payer's perspectiveRobert J Rubin, John A Glaspy, John L Adams, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 22, 2026
Cost-effectiveness of control-IQ automated insulin delivery in adults with type 1 diabetes in SwedenJohan Jendle, Nuno Picado, Carolina Bulhosa, et al.
The American Journal of Managed Care|January 9, 2026
HEDIS glycemic goal achieved using control-IQ TechnologyBimal V Patel, Sharon M Wang, Laurel H Messer, et al.
Diabetes, Obesity & Metabolism|May 5, 2026
Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients With Type 2 Diabetes in the United StatesNeda Al Rawashdh, Bimal V Patel, Sharon M Wang, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 4, 2025
Retrospective analysis of impact of automated insulin delivery technology on acute care utilisation from 2019 to 2021Janna Manjelievskaia, Viral N Shah, Anders L Carlson, et al.
Pageof 2